17-Nov-2021
The Independent
There is evidence of a potential conflict between the CPTPP and the UK’s current system of market authorisation of generic and biosimilar drugs.
20-Sep-2021
Socialist Project
Transnational companies today rely more than ever on IPR to structure their global value chains, writes Peter Rossman
8-Sep-2021
Globalization and Health
Given the potential for wider use of the ISDS mechanism, strategies to protect public health policy space in the context of both international trade and investment treaty and dispute settlement contexts remain important.
14-Jul-2021
Globalization and Health
This paper examines civil society and health actors’ views of the conditions that successfully contributed to the removal of these measures in RCEP, with a focus on intellectual property and access to medicines.
18-May-2021
The Ecologist
The shadowy parallel court system of major trade agreements makes it difficult for countries to ban broad-spectrum insecticides.
11-May-2021
The Independent
‘It would be grossly hypocritical for the government to allow unsustainable meat to be served in schools and hospitals,’ say critics
25-Feb-2021
The Conversation
The COVID-19 pandemic, and the race to make vaccines and other useful technologies more accessible to people around the world, has once again highlighted the tension between intellectual property rights and the promotion of public health.
3-Nov-2020
Open Democracy
Whether a UK deal with an ’America First’ president, or Biden’s more traditional global trade stance, battles ahead are likely if Britain is to protect its NHS and avoid higher drug prices.
20-Oct-2020
Friends of the Earth International
Our call to suspend all ISDS cases during and beyond the COVID-19 crisis.